XML 16 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
shares in Millions, $ in Millions
Total
Number of shares of common stock [Member]
Common stock and additional paid-in capital [Member]
Accumulated deficit [Member]
Accumulated other comprehensive loss [Member]
Beginning Balance, Shares at Dec. 31, 2018   629.6      
Balance as of beginning of period at Dec. 31, 2018 $ 12,500   $ 31,246 $ (17,977) $ (769)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income for basic and diluted EPS 1,992     1,992  
Other comprehensive income (loss), net of taxes 253       253
Dividends declared on common stock (879)     (879)  
Issuance of common stock in connection with the Company’s equity award programs, Shares   0.7      
Issuance of common stock in connection with the Company’s equity award programs 6   6    
Stock-based compensation expense 64   64    
Tax impact related to employee stock-based compensation expense (73)   (73)    
Repurchases of common stock, Shares   (15.9)      
Repurchases of common stock (3,031)     (3,031)  
Ending Balance, Shares at Mar. 31, 2019   614.4      
Balance as of end of period at Mar. 31, 2019 10,832   31,243 (19,895) (516)
Beginning Balance, Shares at Dec. 31, 2018   629.6      
Balance as of beginning of period at Dec. 31, 2018 12,500   31,246 (17,977) (769)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income for basic and diluted EPS 4,171        
Ending Balance, Shares at Jun. 30, 2019   602.1      
Balance as of end of period at Jun. 30, 2019 10,794   31,313 (20,054) (465)
Beginning Balance, Shares at Mar. 31, 2019   614.4      
Balance as of beginning of period at Mar. 31, 2019 10,832   31,243 (19,895) (516)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income for basic and diluted EPS 2,179     2,179  
Other comprehensive income (loss), net of taxes 51       51
Issuance of common stock in connection with the Company’s equity award programs, Shares   0.8      
Issuance of common stock in connection with the Company’s equity award programs 23   23    
Stock-based compensation expense 97   97    
Tax impact related to employee stock-based compensation expense (50)   (50)    
Repurchases of common stock, Shares   (13.1)      
Repurchases of common stock (2,349)     (2,349)  
Other 11     11  
Ending Balance, Shares at Jun. 30, 2019   602.1      
Balance as of end of period at Jun. 30, 2019 10,794   31,313 (20,054) (465)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Cumulative effect of changes in accounting principles, net of taxes $ (2)     (2)  
Beginning Balance, Shares at Dec. 31, 2019 591.4 591.4      
Balance as of beginning of period at Dec. 31, 2019 $ 9,673   31,531 (21,330) (528)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income for basic and diluted EPS 1,825     1,825  
Other comprehensive income (loss), net of taxes (134)       (134)
Dividends declared on common stock (938)     (938)  
Issuance of common stock in connection with the Company’s equity award programs, Shares   0.9      
Issuance of common stock in connection with the Company’s equity award programs 10   10    
Stock-based compensation expense 52   52    
Tax impact related to employee stock-based compensation expense (68)   (68)    
Repurchases of common stock, Shares   (4.3)      
Repurchases of common stock (933)     (933)  
Ending Balance, Shares at Mar. 31, 2020   588.0      
Balance as of end of period at Mar. 31, 2020 $ 9,485   31,525 (21,378) (662)
Beginning Balance, Shares at Dec. 31, 2019 591.4 591.4      
Balance as of beginning of period at Dec. 31, 2019 $ 9,673   31,531 (21,330) (528)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income for basic and diluted EPS $ 3,628        
Ending Balance, Shares at Jun. 30, 2020 586.4 586.4      
Balance as of end of period at Jun. 30, 2020 $ 10,659   31,610 (20,168) (783)
Beginning Balance, Shares at Mar. 31, 2020   588.0      
Balance as of beginning of period at Mar. 31, 2020 9,485   31,525 (21,378) (662)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income for basic and diluted EPS 1,803     1,803  
Other comprehensive income (loss), net of taxes (121)       (121)
Issuance of common stock in connection with the Company’s equity award programs, Shares   1.0      
Issuance of common stock in connection with the Company’s equity award programs 65   65    
Stock-based compensation expense 101   101    
Tax impact related to employee stock-based compensation expense (81)   (81)    
Repurchases of common stock, Shares   (2.6)      
Repurchases of common stock (591)     (591)  
Other $ (2)     (2)  
Ending Balance, Shares at Jun. 30, 2020 586.4 586.4      
Balance as of end of period at Jun. 30, 2020 $ 10,659   $ 31,610 $ (20,168) $ (783)